Skip to content
Tenfell
Awarded contract
Published 30 Oct 2024

Oncotype Dx Gene Expression Profiling Test

Health Service Executive (HSE) · Ireland

Key facts

Contract value
€19,200,000
Buyer type
Health

Description

Gene Expression Profiling (GEP) tests are intended to provide information on disease prognosis and some may also be able to identify the patients who are most likely to benefit from chemotherapy. In this way they support clinical decision-making regarding a patient’s need for adjuvant chemotherapy. This test is used to inform decision-making in relation to the management of early-stage invasive breast cancer. The Oncotype Dx has been contracted for use in Ireland since 2011.

Categories (CPV)

Similar open tenders

About Health Service Executive (HSE)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on TED (Tenders Electronic Daily) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.